ACTRN12612000337875招募中未知
Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry
Australasian Leukaemia and Lymphoma Group0 个研究点目标入组 2,000 人开始时间: 2012年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 15 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Male or female with a suspected, or known, or diagnosed blood cancer
- •2. Aged 15 and over
- •3. Has provided written informed consent
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
2 期
A study for patients with newly diagnosed Chronic Phase Myeloid Leukaemia evaluating the drug Asciminib.ACTRN12620000851965Australiasian Leukaemia and Lymphoma Group101
招募中
2 期
HL35: A study of Pembrolizumab And Chemo-Immunotherapy as FIrst-line therapy for patients with primary mediastinal B-Cell lymphoma.Primary mediastinal B-cell lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12621001529831Australasian Lymphoma and Leukaemia Group35
已完成
不适用
MRC ALL 97 - UK national lymphoblastic leukaemia (ALL) trialeukaemiaLymphoblastic leukaemiaCancerISRCTN26727615Medical Research Council (MRC) (UK)1,800
招募中
不适用
Australian and New Zealand Lymphoma and Related Diseases RegistryymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - Leukaemia - Chronic leukaemiaLymphomaACTRN12617000050358Monash University8,000
已完成
不适用
Medical Research Council Acute Lymphoblastic Leukaemia Trial in Children UKALL R1eukaemia (acute)CancerLeukaemiaISRCTN13327255Medical Research Council (MRC) (UK)256